• +44 7723 493307
  • info-ucg@utilitarianconferences.com
Login
WhatsApp

Track 14: Lung cancer

Track 14: Lung cancer

Sub tracks of lungs cancer:

1. Origin & Risk Factors

  • Genetic mutations (e.g., EGFR, ALK)
  • Environmental factors (e.g., smoking, pollution, asbestos)
  • Pre-cancerous changes
  •  Types of Lung Cancer
  • Non-Small Cell Lung Cancer (NSCLC):
    • Adenocarcinoma
    • Squamous cell carcinoma
    • Large cell carcinoma
  • Small Cell Lung Cancer (SCLC):
    • Limited stage
    • Extensive stage

    Stages of Cancer

  • Stage 0 (In Situ): Cancer cells localized
  • Stage I: Small tumor, no lymph node involvement
  • Stage II: Tumor with nearby lymph node involvement
  • Stage III: Advanced regional spread
  • Stage IV: Metastatic (spread to other organs)

   Diagnostic Techniques

  • Imaging: X-rays, CT scans, PET scans
  • Biopsy: Tissue sampling
  • Molecular testing: Mutation markers (e.g., EGFR, KRAS)

     Treatment Tracks

  • Surgery: Early-stage cancer
  • Radiation Therapy: Localized or advanced stages
  • Chemotherapy: Systemic treatment
  • Targeted Therapy: EGFR inhibitors, ALK inhibitors
  • Immunotherapy: PD-1/PD-L1 inhibitors
  • Palliative Care: Advanced stages for symptom relief

     Prognosis and Monitoring

  • Regular scans and tests
  • Management of recurrence
  • Clinical trials and emerging therapies

    What is Lungs cancer ?
    Lung cancer is a type of cancer that begins in the lungs, commonly caused by smoking, exposure to harmful substances, or genetic factors. It involves abnormal cell growth, forming tumors that can interfere with breathing and spread to other parts of the body.